FBXL15 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.496050E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.195560E-01
Normal-vs-Stage2
1.523010E-01
Normal-vs-Stage3
6.896600E-01
Normal-vs-Stage4
7.523400E-01
Stage1-vs-Stage2
2.632300E-02
Stage1-vs-Stage3
1.495950E-01
Stage1-vs-Stage4
1.114200E-01
Stage2-vs-Stage3
4.629600E-01
Stage2-vs-Stage4
2.198800E-01
Stage3-vs-Stage4
7.640800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.793510E-02
Normal-vs-AfricanAmerican
9.053600E-01
Normal-vs-Asian
1.231600E-01
Caucasian-vs-AfricanAmerican
6.388200E-01
Caucasian-vs-Asian
2.753000E-01
AfricanAmerican-vs-Asian
3.072600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.259630E-02
Normal-vs-Female
1.810440E-01
Male-vs-Female
4.146600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.646200E-01
Normal-vs-Age(41-60Yrs)
1.998030E-01
Normal-vs-Age(61-80Yrs)
5.160400E-02
Normal-vs-Age(81-100Yrs)
1.119430E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.224400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.596200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.908400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.085000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.051000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.582800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.018500E-02
Normal-vs-Daily Drinker
4.338600E-03
Normal-vs-Weekly Drinker
1.660440E-01
Normal-vs-Occasional Drinker
1.702760E-01
Normal-vs-Social Drinker
6.549600E-01
Non Drinker-vs-Daily Drinker
7.842200E-02
Non Drinker-vs-Weekly Drinker
5.358600E-01
Non Drinker-vs-Occasional Drinker
4.871800E-01
Non Drinker-vs-Social Drinker
4.279000E-01
Daily Drinker-vs-Weekly Drinker
5.448200E-01
Daily Drinker-vs-Occasional Drinker
6.837400E-01
Daily Drinker-vs-Social Drinker
5.620000E-02
Weekly Drinker-vs-Occasional Drinker
9.081600E-01
Weekly Drinker-vs-Social Drinker
3.117400E-01
Occasional Drinker-vs-Social Drinker
3.029400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.880400E-01
Normal-vs-Grade 2
2.874600E-01
Normal-vs-Grade 3
2.196400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.210430E-01
Grade 1-vs-Grade 3
1.960790E-01
Grade 1-vs-Grade 4
3.880400E-01
Grade 2-vs-Grade 3
5.618600E-01
Grade 2-vs-Grade 4
2.874600E-01
Grade 3-vs-Grade 4
2.196400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.692200E-02
Normal-vs-NonDiabetic
2.280400E-03
Diabetic-vs-NonDiabetic
6.036600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.403500E-03
Normal-vs-NoPancreatitis
5.443300E-03
Pancreatitis-vs-NoPancreatitis
2.339400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.581200E-03
Normal-vs-N1
3.531600E-01
N0-vs-N1
3.408500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.346200E-01
Normal-vs-TP53-NonMutant
2.183400E-01
TP53-Mutant-vs-TP53-NonMutant
6.708400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
